BriaCell Therapeutics

+$0.23 (+3.01%) Today
+$0.11 (+1.40%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCTX and other ETFs, options, and stocks.

About BCTX

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.

CEO
William V. Williams
Employees
—
Headquarters
West Vancouver, British Columbia
Founded
2006

BCTX Key Statistics

Market Cap
120.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.09M
High Today
$8.00
Low Today
$7.60
Open Price
$7.77
Volume
1.12M
52 Week High
$9.50
52 Week Low
$2.81

BCTX Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Feb 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure